Literature DB >> 10511519

The human ehrlichioses in the United States.

J H McQuiston1, C D Paddock, R C Holman, J E Childs.   

Abstract

The emerging tick-borne zoonoses human monocytic ehrlichiosis (HME) and human granulocytic ehrlichiosis (HGE) are under reported in the United States. From 1986 through 1997, 1,223 cases (742 HME, 449 HGE, and 32 not ascribed to a specific ehrlichial agent) were reported by state health departments. HME was most commonly reported from southeastern and southcentral states, while HGE was most often reported from northeastern and upper midwestern states. The annual number of reported cases increased sharply, from 69 in 1994 to 364 in 1997, coincident with an increase in the number of states making these conditions notifiable. From 1986 through 1997, 827 probable and confirmed cases were diagnosed by serologic testing at the Centers for Disease Control and Prevention, although how many of these cases were also reported by states is not known. Improved national surveillance would provide a better assessment of the public health importance of ehrlichiosis.

Entities:  

Mesh:

Year:  1999        PMID: 10511519      PMCID: PMC2627718          DOI: 10.3201/eid0505.990504

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  13 in total

1.  Perinatal transmission of the agent of human granulocytic ehrlichiosis.

Authors:  H W Horowitz; E Kilchevsky; S Haber; M Aguero-Rosenfeld; R Kranwinkel; E K James; S J Wong; F Chu; D Liveris; I Schwartz
Journal:  N Engl J Med       Date:  1998-08-06       Impact factor: 91.245

2.  Ixodes pacificus (Acari: Ixodidae) as a vector of Ehrlichia equi (Rickettsiales: Ehrlichieae).

Authors:  P J Richter; R B Kimsey; J E Madigan; J E Barlough; J S Dumler; D L Brooks
Journal:  J Med Entomol       Date:  1996-01       Impact factor: 2.278

3.  Epidemiologic, clinical, and laboratory findings of human ehrlichiosis in the United States, 1988.

Authors:  T R Eng; J R Harkess; D B Fishbein; J E Dawson; C N Greene; M A Redus; F T Satalowich
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

4.  Serologic testing for human granulocytic ehrlichiosis at a national referral center.

Authors:  J A Comer; W L Nicholson; J G Olson; J E Childs
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease.

Authors:  S M Chen; J S Dumler; J S Bakken; D H Walker
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

6.  Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

Authors:  B E Anderson; J E Dawson; D C Jones; K H Wilson
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

7.  Statewide surveillance for ehrlichiosis--Connecticut and New York, 1994-1997.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1998-06-19       Impact factor: 17.586

8.  Human ehrlichiosis in the United States, 1985 to 1990.

Authors:  D B Fishbein; J E Dawson; L E Robinson
Journal:  Ann Intern Med       Date:  1994-05-01       Impact factor: 25.391

9.  Human granulocytic ehrlichiosis--New York, 1995.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1995-08-18       Impact factor: 17.586

10.  Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.

Authors:  P Pancholi; C P Kolbert; P D Mitchell; K D Reed; J S Dumler; J S Bakken; S R Telford; D H Persing
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

View more
  50 in total

1.  Prevalence of Ehrlichia ewingii in Amblyomma americanum in North Carolina.

Authors:  L Wolf; T McPherson; B Harrison; B Engber; A Anderson; P Whitt
Journal:  J Clin Microbiol       Date:  2000-07       Impact factor: 5.948

2.  Ehrlichia chaffeensis induces monocyte inflammatory responses through MyD88, ERK, and NF-κB but not through TRIF, interleukin-1 receptor 1 (IL-1R1)/IL-18R1, or toll-like receptors.

Authors:  Koshiro Miura; Junji Matsuo; M Akhlakur Rahman; Yumi Kumagai; Xin Li; Yasuko Rikihisa
Journal:  Infect Immun       Date:  2011-09-19       Impact factor: 3.441

3.  Renal, hepatic, and marrow dysfunction in a patient with chronic renal insufficiency.

Authors:  Rebecca C Brady; John J Bissler
Journal:  Pediatr Nephrol       Date:  2003-02-12       Impact factor: 3.714

4.  Polymorphism and transcription at the p44-1/p44-18 genomic locus in Anaplasma phagocytophilum strains from diverse geographic regions.

Authors:  Quan Lin; Yasuko Rikihisa; Robert F Massung; Zerai Woldehiwet; Richard C Falco
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

5.  The low seroprevalence of tick-transmitted agents of disease in dogs from southern Ontario and Quebec.

Authors:  Anthony T Gary; Jinelle A Webb; Barbara C Hegarty; Edward B Breitschwerdt
Journal:  Can Vet J       Date:  2006-12       Impact factor: 1.008

Review 6.  Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen.

Authors:  David H Walker; Nahed Ismail; Juan P Olano; Jere W McBride; Xue-Jie Yu; Hui-Min Feng
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

7.  Penicillin-binding protein of Ehrlichia chaffeensis: cytokine induction through MyD88-dependent pathway.

Authors:  Mohd Akhlakur Rahman; Zhihui Cheng; Junji Matsuo; Yasuko Rikihisa
Journal:  J Infect Dis       Date:  2012-04-26       Impact factor: 5.226

8.  Comparison of PCR assays for detection of the agent of human granulocytic ehrlichiosis, Anaplasma phagocytophilum.

Authors:  Robert F Massung; Kimetha G Slater
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Multiplex real-time PCR for detection of anaplasma phagocytophilum and Borrelia burgdorferi.

Authors:  Joshua W Courtney; Leah M Kostelnik; Nordin S Zeidner; Robert F Massung
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  Cytokine gene expression by peripheral blood leukocytes in horses experimentally infected with Anaplasma phagocytophila.

Authors:  Hyung-Yong Kim; Jason Mott; Ning Zhi; Tomoko Tajima; Yasuko Rikihisa
Journal:  Clin Diagn Lab Immunol       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.